GLO1 and amyotrophic lateral sclerosis: Currently there are limited data focusing on methylglyoxal and its removal in ALS (Sirangelo et al., 2016) and to the best of our knowledge, this is the first study to suggest that GLO1 levels are altered in ALS patient-derived cell models.